Company profile
Anchiano Therapeutics company profile
Anchiano is a biopharmaceutical company that specializes in the development of Targeted Cancer Therapies for the treatment of numerous types of cancer. The Company's technology offers a safe and long-term treatment of cancer, with no adverse effects. BioCancell was co-founded in 2004 by Professor Avraham Hochberg, Professor of Molecular Biology at the Hebrew University of Jerusalem, based on technology developed by him over the past 25 years. The drug candidates developed by the Company are targeted and their goal is to selectively destroy the cancer cells without affecting healthy cells (‘Targeted Cancer Therapy'). The approach is based on the identification..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- https://www.anchiano.com/
- Contact email
- [email protected]
- Phone number
- 857-259-4622
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2004-01-01
Headquarters
- Headquarters
- Sumbul, North Sumatra, Indonesia
- Postal code
- 97775
- Country code
- ID
- Continent
- Asia